In Greek mythology, Tithonus was granted eternal life but not eternal youth. As time passes he withers, slowly losing his health and all that he knew, lamenting a cruel immortality.1
Get full access to this article
View all access options for this article.
References
1.
Lord TennysonA: Tithonus. Cornhill Magazine, 1860.
2.
Antiretroviral Therapy Cohort Collaboration: Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. Lancet HIV, 2017; 4:e349–e356.
3.
DeeksSG, TracyR, DouekDC: Systemic effects of inflammation on health during chronic HIV infection. Immunity, 2013; 39:633–645.
4.
ErlandsonKM, AllshouseAA, JankowskiCM, MawhinneyS, KohrtWM, CampbellTB: Relationship of physical function and quality of life among persons aging with HIV infection. AIDS, 2014; 28:1939–1943.
5.
GreeneM, CovinskyK, AstemborskiJ, et al.: The relationship of physical performance with HIV disease and mortality. AIDS (London, England), 2014; 28:2711–2719.
6.
MillsEJ, BarnighausenT, NeginJ: HIV and aging—Preparing for the challenges ahead. N Engl J Med, 2012; 366:1270–1273.
7.
NixonDE, LandayAL: Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS, 2010; 5:498–503.
8.
WadaN, JacobsonLP, CohenM, FrenchA, PhairJ, MunozA: Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984–2008. Am J Epidemiol, 2013; 177:116–125.
9.
LevinJ. Available at www.natap.org (2019).
10.
SieglerEL, BurchettCO, GlesbyMJ: Older people with HIV are an essential part of the continuum of HIV care. J Int AIDS Soc, 2018; 21:e25188.
11.
SinghHK, Del CarmenT, FreemanR, GlesbyMJ, SieglerEL: From one syndrome to many: Incorporating geriatric consultation into HIV care. Clin Infect Dis, 2017; 65:501–506.
12.
EdelmanEJ, GordonKS, GloverJ, McNichollIR, FiellinDA, JusticeAC: The next therapeutic challenge in HIV: polypharmacy. Drugs Aging, 2013; 30:613–628.
13.
BektasA, SchurmanSH, SenR, FerrucciL: Aging, inflammation and the environment. Exp Gerontol, 2018; 105:10–18.
14.
FranceschiC, CampisiJ: Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci, 2014; 69Suppl 1:S4–S9.
15.
FranceschiC, CapriM, MontiD, et al.: Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev, 2007; 128:92–105.
16.
NasiM, De BiasiS, GibelliniL, et al.: Ageing and inflammation in patients with HIV infection. Clin Exp Immunol, 2017; 187:44–52.
17.
Baldwin JrAS: Series introduction: The transcription factor NF-kappaB and human disease. J Clin Invest, 2001; 107:3–6.
18.
BektasA, SchurmanSH, SenR, FerrucciL: Human T cell immunosenescence and inflammation in aging. J Leukoc Biol, 2017; 102:977–988.
19.
AlthoffKN, JacobsonLP, CranstonRD, et al.; Study ftMAC: Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci, 2014; 69A:189–198.
20.
DesquilbetL, JacobsonLP, FriedLP, et al.: HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci, 2007; 62:1279–1286.
21.
ErlandsonK, AllshouseAA, JankowskiCM, et al.: Comparison of functional status instruments in HIV-infected adults on effective antiretroviral therapy. Hiv Clinical Trials, 2012; 13:324–334.
SchrackJA, JacobsonLP, AlthoffKN, et al.: Effect of HIV-infection and cumulative viral load on age-related decline in grip strength. AIDS, 2016; 30:2645–2652.
24.
TranT, GuardigniV, PencinaKM, et al.: Atypical skeletal muscle profiles in human immunodeficiency virus-infected asymptomatic middle-aged adults. Clin Infect Dis, 2018; 66:1918–1927.
